No abstract available
Keywords:
acenocoumarol; algorithm; apixaban; coumarinic oral anticoagulants; dabigatran; edoxaban; epigenetics; epigenomics; non-VKA oral anticoagulants; pharmacoepigenomics; pharmacogenomics; rivaroxaban; warfarin.
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Blood Coagulation / drug effects*
-
Blood Coagulation / genetics
-
Blood Coagulation Disorders / drug therapy*
-
Blood Coagulation Disorders / genetics
-
Dabigatran / adverse effects
-
Dabigatran / therapeutic use
-
Humans
-
Pharmacogenetics*
-
Warfarin / adverse effects
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Warfarin
-
Dabigatran